64
In band
Moving averages
SMA 200$225.18+17.67%
Company profile
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$438.19B
P/E ratio69.46
EPS$3.57
Beta0.28
Dividend yield2.78%
52-week high$267.47
52-week low$189.40
Similar stocks in Drug Manufacturers - General
RSI alerts for ABBV
Get an email the moment AbbVie Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 12 August 2026 at 3:26 AM EDT